Design, synthesis and biological evaluation of oxygenated chalcones as potent and selective MAO-B inhibitors

被引:58
|
作者
Parambi, Della Grace Thomas [1 ]
Oh, Jong Min [2 ,3 ]
Baek, Seung Cheol [2 ,3 ]
Lee, Jae Pil [2 ,3 ]
Tondo, Anna Rita [4 ]
Nicolotti, Orazio [5 ]
Kim, Hoon [2 ,3 ]
Mathew, Bijo [6 ,7 ]
机构
[1] Jouf Univ, Dept Pharmaceut Chem, Sakaka 2014, Al Jouf, Saudi Arabia
[2] Sunchon Natl Univ, Dept Pharm, Sunchon 57922, South Korea
[3] Sunchon Natl Univ, Res Inst Life Pharmaceut Sci, Sunchon 57922, South Korea
[4] Ist Ric Farmacol Mario Negri IRCCS, Via Masa 19, I-20156 Milan, Italy
[5] Univ Bari Aldo Moro, Dipartimento Farm Sci Farmaco, Via E Orabona 4, I-70125 Bari, Italy
[6] Ahalia Sch Pharm, Dept Pharmaceut Chem, Div Drug Design, Palakkad 678557, Kerala, India
[7] Ahalia Sch Pharm, Dept Pharmaceut Chem, Med Chem Res Lab, Palakkad 678557, Kerala, India
基金
新加坡国家研究基金会;
关键词
Chalcone; MAO inhibition; Kinetics; Reversibility; Molecular docking; MONOAMINE-OXIDASE-B; 2H-CHROMEN-2-ONE DERIVATIVES; THIENYL CHALCONES; BIOCHEMISTRY; IDENTIFICATION; MECHANISM; DISCOVERY; INSIGHTS;
D O I
10.1016/j.bioorg.2019.103335
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The present study documents the synthesis of oxygenated chalcone (O1-O26) derivatives and their abilities to inhibit monoamine oxidases. All 26 derivatives examined showed potent inhibitory activity against MAO-B. Compound O23 showed the greatest inhibitory activity against MAO-B with an IC50 value of 0.0021 mu M, followed by compounds O10 and O17 (IC50 = 0.0030 and 0.0034 mu M, respectively). In addition, most of the derivatives potently inhibited MAO-A and O6 was the most potent inhibitor with an IC50 value of 0.029 mu M, followed by O3, O4, O9, and O2 (IC50 = 0.035, 0.053, 0.072, and 0.082 mu M, respectively). O23 had a high selectivity index (SI) value for MAO-B of 138.1, and O20 (IC50 value for MAO-B= 0.010 mu M) had an extremely high SI of >4000. In dialysis experiments, inhibitions of MAO-A and MAO-B by O6 and O23, respectively, were recovered to their respective reversible reference levels, demonstrating both are reversible inhibitors. Kinetic studies revealed that O6 and O23 competitively inhibited MAO-A and MAO-B, respectively, with respective Ki values of 0.016 +/- 0.0007 and 0.00050 +/- 0.00003 mu M. Lead compound are also non-toxic at 200 mu g/mL in normal rat spleen cells. Molecular docking simulations and subsequent Molecular Mechanics/Generalized Born Surface Area calculations provided a rationale that explained experimental data.
引用
收藏
页数:10
相关论文
共 50 条
  • [41] Selective MAO-B Inhibitors have Low Potential for the Tyramine Effect
    Isaacson, Stuart H.
    MOVEMENT DISORDERS, 2010, 25 (01) : 123 - 124
  • [42] Design, synthesis and evaluation of novel monoamine oxidase B (MAO-B) inhibitors with improved pharmacokinetic properties for Parkinson?s disease
    Yi, Chao
    Liu, Xinchang
    Chen, Kangzhi
    Liang, Haiping
    Jin, Chuanfei
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2023, 252
  • [43] Synthesis, molecular modeling, 3D-QSAR and biological evaluation studies of new benzimidazole derivatives as potential MAO-A and MAO-B inhibitors
    Erol, Meryem
    Celik, Ismail
    Saglik, Begum Nurpelin
    Karayel, Arzu
    Mellado, Marco
    Mella, Jaime
    JOURNAL OF MOLECULAR STRUCTURE, 2022, 1265
  • [44] DESIGN, SYNTHESIS, BIOLOGICAL EVALUATION AND MOLECULAR DOCKING OF PYRROLE-BASED COMPOUNDS AS ANTIOXIDANT AND MAO-B INHIBITORY AGENTS
    Mateev, Emilio
    Angelov, Borislav
    Kondeva-Burdina, Magdalena
    Valkova, Iva
    Georgieva, Maya
    Zlatkov, Alexander
    FARMACIA, 2022, 70 (02) : 344 - 354
  • [45] Design and synthesis of 8-substituted benzamido-phenylxanthine derivatives as MAO-B inhibitors
    Song, Bo
    Xiao, Tong
    Qi, Xiaolu
    Li, Ling-Na
    Qin, Kuiyou
    Nian, Siyun
    Hu, Guo-Xin
    Yu, Yinfei
    Liang, Guang
    Ye, Faqing
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2012, 22 (04) : 1739 - 1742
  • [46] Design, Synthesis and Biological Evaluation of Caudatin Analogs as Potent Hepatitis B Virus Inhibitors
    Wang, Li-Jun
    Chen, Hao
    Ma, Yun-Bao
    Huang, Xiao-Yan
    Geng, Chang-An
    Zhang, Xue-Mei
    Chen, Ji-Jun
    MEDICINAL CHEMISTRY, 2015, 11 (02) : 165 - 179
  • [47] Trimethoxylated Halogenated Chalcones as Dual Inhibitors of MAO-B and BACE-1 for the Treatment of Neurodegenerative Disorders
    Koyiparambath, Vishal Payyalot
    Oh, Jong Min
    Khames, Ahmed
    Abdelgawad, Mohamed A.
    Nair, Aathira Sujathan
    Nath, Lekshmi R.
    Gambacorta, Nicola
    Ciriaco, Fulvio
    Nicolotti, Orazio
    Kim, Hoon
    Mathew, Bijo
    PHARMACEUTICS, 2021, 13 (06)
  • [48] Structure-Based Design of Novel MAO-B Inhibitors: A Review
    Mateev, Emilio
    Georgieva, Maya
    Mateeva, Alexandrina
    Zlatkov, Alexander
    Ahmad, Shaban
    Raza, Khalid
    Azevedo, Vasco
    Barh, Debmalya
    MOLECULES, 2023, 28 (12):
  • [49] Pyridazinones containing dithiocarbamoyl moieties as a new class of selective MAO-B inhibitors
    Besada, Pedro
    Vina, Dolores
    Costas, Tamara
    Costas-Lago, Maria Carmen
    Vila, Noemi
    Torres-Teran, Iria
    Sturlese, Mattia
    Moro, Stefano
    Teran, Carmen
    BIOORGANIC CHEMISTRY, 2021, 115
  • [50] Design, Synthesis, and Biological Evaluation of 2-Aminobenzanilide Derivatives as Potent and Selective HDAC Inhibitors
    Stolfa, Diana A.
    Stefanachi, Angela
    Gajer, Julia M.
    Nebbioso, Angela
    Altucci, Lucia
    Cellamare, Saverio
    Jung, Manfred
    Carotti, Angelo
    CHEMMEDCHEM, 2012, 7 (07) : 1256 - 1266